Why TransEnterix Stock Is Rebounding Today
TransEnterix (NYSEMKT: TRX), a small-cap robotic-surgery company, is on the rebound today with its shares up by 21.41% on heavy volume, as of 11:05 a.m. EDT.
Prior to today's double-digit move, TransEnterix's stock had fallen by more than 40% following the FDA approval of its minimally invasive robotic-surgery system, Senhance, earlier this month, which initially sparked the company's shares to rise by more than 200% in a single day.
Image source: Getty Images.
Source: Fool.com
Johnson & Johnson Aktie
221,55 €
0,14 %
Einzigartige Zustimmung für Johnson & Johnson mit ausschließlich Buy-Einschätzungen.
Ein leicht positives Potenzial wird für Johnson & Johnson mit einem Kursziel von 228 € im Vergleich zu 221.55 € gesehen.
